RCC asked to explain drug unavailability

SHRC seeks report in four weeks

July 05, 2019 01:09 am | Updated 01:09 am IST - Thiruvananthapuram

The State Human Rights Commission (SHRC) has asked the Director of the Regional Cancer Centre (RCC) here to submit a report as to why essential drugs required for blood cancer patients are not available at the RCC pharmacy.

In a complaint before the SHRC, it was pointed out that the parents of children who are under treatment for Acute Lymphoblastic Leukemia, were running from pillar to post to procure certain drugs (Mercaptopurine, Methotrexate), as these drugs have not been available in RCC pharmacy since months. The complaint said that these drugs used to be available for free in RCC pharmacy earlier. The drugs are currently unavailable in the open market.

The SHRC has asked that a report be submitted to it within four weeks.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.